You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

visceral lesions

Showing 1 - 25 of 7,362
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bone and Visceral Lesions of Type 1 Gaucher Disease Treated With

Completed
  • Gaucher Disease, Type 1
  • MRI
  • MRI
  • Clichy, France
    Beaujon Hospital
Jun 16, 2021

Laparoscopy, Augmented Reality, Orientation, Spatial Trial in Cologne (Method A, Method B)

Not yet recruiting
  • Laparoscopy
  • +3 more
  • Method A
  • Method B
  • Cologne, Germany
    University of Cologne, Department of General, Visceral and Cance
Aug 14, 2022

Anogenital Human Papillomavirus Infection, Condyloma Anal Trial in Innsbruck (Imiquimod 5% cream, Placebo cream, Fulguration)

Not yet recruiting
  • Anogenital Human Papillomavirus Infection
  • Condyloma Anal
  • Imiquimod 5% cream
  • +2 more
  • Innsbruck, Tyrol, Austria
    Visceral-, Transplant- and Thoracic Surgery
Sep 22, 2020

Solid Tumors, Lymphoma Trial in Worldwide (Ulevostinag, Pembrolizumab)

Completed
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +18 more
Jun 10, 2022

Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Recruiting
  • Leishmaniasis
  • +2 more
    • Lankien, Jonglei, South Sudan
      Lankien Hospital
    Jul 4, 2022

    Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

    Recruiting
    • Metastatic Cancer
    • +2 more
    • ASP9801
    • Pembrolizumab
    • Birmingham, Alabama
    • +26 more
    Jan 6, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +6 more
    • San Francisco, California
      University of California, San Francisco
    Sep 8, 2022

    Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

    Not yet recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer
    • (no location specified)
    Nov 10, 2023

    Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

    Not yet recruiting
    • Cutaneous Tumor
    • Malignant Solid Tumor
    • JCXH-211 Injection
    • (no location specified)
    Feb 13, 2023

    Advanced Solid Tumours Trial in France, Spain, United States (Ceralasertib)

    Recruiting
    • Advanced Solid Tumours
    • Tucson, Arizona
    • +31 more
    Jan 13, 2023

    Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
    • RP3
    • +3 more
    • (no location specified)
    Feb 21, 2023

    Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer Trial in United States (mRNA-2416, Durvalumab)

    Terminated
    • Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
    • Ovarian Cancer
    • mRNA-2416
    • Durvalumab
    • Aurora, Colorado
    • +8 more
    Jul 7, 2022

    Tumors Trial in Lausanne (18F-FDG PET/CT)

    Recruiting
    • Neoplasms
    • 18F-FDG PET/CT
    • Lausanne, Vaus, Switzerland
      Centre Hospitalier Universitaire Vaudois
    Jun 11, 2022

    Endometriosis Trial in Amsterdam (spinal cord stimulator)

    Not yet recruiting
    • Endometriosis
    • spinal cord stimulator
    • Amsterdam, Noord Holland, Netherlands
      Amsterdam UMC, location VUmc
    Sep 23, 2022

    National Retrospective Study of Duodenal Trauma

    Recruiting
    • Duodenal Diverticulization
    • +6 more
    • Observational
    • Nice, Alpes Maritimes, France
      CHU de Nice
    Sep 28, 2023

    Esophageal Tumors, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (drug, radiation, procedure)

    Completed
    • Esophageal Neoplasms
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 23, 2021

    Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial (Standard ADT (androgen deprivation therapy), Standard Darolutamide,

    Not yet recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • Standard ADT (androgen deprivation therapy)
    • +2 more
    • (no location specified)
    Jan 6, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 16, 2023

    Disorder of Pleura and Pleural Cavity Trial (medical thoracoscope, Forceps biopsy and pleural brush histopathology, pleural

    Not yet recruiting
    • Disorder of Pleura and Pleural Cavity
    • medical thoracoscope
    • +2 more
    • (no location specified)
    Sep 27, 2023

    Breast Tumors Trial in Worldwide (Xentuzumab, Placebo, Everolimus)

    Completed
    Has Results
    • Breast Neoplasms
    • Chandler, Arizona
    • +53 more
    Dec 13, 2022

    Prostate Cancer Trial in San Francisco (Ga-68 labeled PSMA-11 PET)

    Completed
    Has Results
    • Prostate Cancer
    • Ga-68 labeled PSMA-11 PET
    • San Francisco, California
      University of California, San Francisco
    Sep 22, 2021

    Multiple Sclerosis, Pelvic Floor Disorders, Urinary Incontinence Trial in Gaziantep (breathing exercises, osteopathic manual

    Recruiting
    • Multiple Sclerosis
    • +4 more
    • breathing exercises
    • osteopathic manual therapy techniques
    • Gaziantep, Turkey
      Tuba Maden
    Jul 31, 2023

    Blunt Abdominal Trauma in Pediatric Emergency

    Not yet recruiting
    • Blunt Abdominal Trauma in Children
    • Identifying Intra Abdominal Injuries
      • Nancy, France
        Marine Pettini
      Jul 20, 2021

      Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

      Recruiting
      • Hematopoietic and Lymphoid System Neoplasm
      • Malignant Solid Neoplasm
      • Computed Tomography
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      May 3, 2023

      Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

      Not yet recruiting
      • Malignant Melanoma
      • Liver Metastases
      • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
      • (no location specified)
      Dec 23, 2022